Segmed's Imaging Solution Integrated into Bayer's AI Healthcare Platform

Segmed has announced a partnership with Bayer to integrate its leading real-world imaging data (RWiD) solution into Bayer's AI Innovation Platform (AIIP). This collaboration aims to accelerate the development of AI-powered healthcare applications by providing researchers and developers from various sectors (academia, solution providers, healthcare organizations, and startups) with access to high-quality, diverse real-world medical imaging data. Through Segmed’s cohort builder and imaging data, hosted on Bayer's cloud-based platform, the partnership seeks to support the creation of scalable, compliant AI-driven medical imaging software products.

"Being part of a comprehensive AI development environment has been a key vision for Segmed, and we are thrilled to bring our expertise in technology-driven, de-identified imaging data to this collaboration with Bayer," said Dr. Martin Willemink, Segmed’s Co-founder and CEO. "Together, we aim to help healthcare organizations efficiently access the right data to build solutions for radiologists, ultimately improving patient outcomes."

Medical imaging data, which makes up around 90% of all healthcare data, is vital for disease screening, diagnosis, and tracking. With billions of images produced annually, managing this growing volume is overwhelming for healthcare professionals. AI tools are being developed to assist in processing and analyzing these images, but they require access to curated real-world medical imaging data, a challenge Segmed addresses with its technology.

Segmed's platform is integrated with a broad network of healthcare partners, providing millions of de-identified imaging studies linked to medical records. Combined with Bayer's expertise in healthcare and regulation, this collaboration has the potential to transform the healthcare ecosystem, enhance patient outcomes, lower costs, support radiologists, and accelerate innovation.